Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.29M Buy
7,603
+3
+0% +$596 0.4% 33
2026
Q1
$1.12M Buy
7,600
+230
+3% +$33.6K 0.24% 61
2025
Q4
$895K Buy
7,370
+3,090
+72% +$362K 0.21% 73
2025
Q3
$461K Sell
4,280
-50
-1% -$4.67K 0.19% 107
2025
Q2
$388K Buy
4,330
+270
+7% +$20.3K 0.18% 115
2025
Q1
$276K Buy
+4,060
New +$292K 0.17% 113
2024
Q4
Sell
-2,710
Closed -$210K 178
2024
Q3
$210K Buy
2,710
+30
+1% +$2.35K 0.14% 132
2024
Q2
$221K Buy
+2,680
New +$198K 0.16% 111

Other funds holding KLAC

Abel Hall LLC's KLAC Position: Q2 2026 in Review

Abel Hall LLC increased its KLA (KLAC) stake by 0.04% in Q2 2026, buying an estimated $596 and bringing the position to 7,603 shares worth $2.29M. The position accounts for 0.4% of the portfolio, ranked #33.

Abel Hall LLC first reported a position in KLAC in Q2 2024 and has held it in 8 quarters since. 926 funds tracked by Wall St. Rank hold KLAC as of Q2 2026.

  • Abel Hall LLC held 7,603 shares of KLA worth $2.29M as of Q2 2026.
  • Abel Hall LLC bought 3 KLA shares in Q2 2026, an estimated $596.
  • KLA made up 0.4% of Abel Hall LLC's portfolio in Q2 2026, its #33 holding.
  • Abel Hall LLC first reported a position in KLA in Q2 2024 and has held it in 8 quarters since.
  • 926 funds tracked by Wall St. Rank held KLA as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.